Novel Candida albicans host receptors during infection and immune response
感染和免疫反应期间新型白色念珠菌宿主受体
基本信息
- 批准号:10231043
- 负责人:
- 金额:$ 23.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAdvisory CommitteesAntifungal AgentsAzole resistanceAzolesBindingCandida albicansCell WallCellsCommittee MembersComplementDataDiabetes MellitusDiseaseElementsEndocytosisEph Family ReceptorsEphrinsEpithelialEpithelial CellsEsophagusFacultyFillerFutureGoalsHead CancerHead and Neck CancerHost DefenseHumanImmuneImmune responseImmunocompromised HostIn VitroIndividualIndustrial fungicideInfectionInflammatoryInflammatory ResponseInnate Immune ResponseInterleukin-17InvadedLeukocytesLifeLigandsLiverMAP Kinase GeneMentorsModelingMolecularMorbidity - disease rateMucosal ImmunityMucous MembraneMusMyeloid CellsNeutropeniaOpportunistic InfectionsOralOral mucous membrane structureOrganismParticulatePathogenesisPatientsPatternPattern recognition receptorPeptidesPhagocytesPhasePhosphorylationPlayPopulation HeterogeneityPositioning AttributePostdoctoral FellowProcessPublic HealthReceptor ActivationReceptor CellResearchResearch InstituteResearch PersonnelResearch TrainingRoleScientistSenior ScientistSignal PathwaySignal TransductionSignaling MoleculeSjogren&aposs SyndromeStat3 proteinSteroidsStructureSurfaceTestingThe science of MycologyTrainingZymosanbeta-Glucansbeta-glucan receptorcareercareer developmentcytokinedesignexperiencefungal microbiotafungusimprovedin vivointerestlaminaranneutrophilnovelnovel strategiesnovel therapeutic interventionnovel therapeuticsoral cavity epitheliumoral fungaloropharyngeal thrushpathogenpatient populationpreventprofessorreceptorresponsestudent training
项目摘要
ABSTRACT/SUMMARY
The polymorphic fungus, Candida albicans is part of the endogenous human mycobiota. It colonizes mucosal
surfaces of 30-70% of healthy individuals. The fungus causes both superficial mucosal diseases and life
threatening invasive infection. Oropharyngeal candidiasis (OPC) causes significant morbidity in a large and
diverse population of patients, including those with HIV/AIDS, Sjogren's syndrome, diabetes mellitus, cancer
of the head and neck, or the use of steroids Nearly 10 million cases of HIV/AIDS associated OPC occur
annually and nearly one fifth of these cases have esophageal involvement. To cause OPC, C. albicans must
adhere to and invade the oral mucosa, and resist being killed by host phagocytes. Dr. Swidergall discovered
that EphA2 on oral epithelial cells and neutrophils is a novel pattern recognition receptor for C. albicans. EphA2
binds exposed β-glucan on the fungal cell walls, and the preliminary data indicate that it plays a key role in the
response of both epithelial cells and neutrophils to the organism.
The central objective of this proposal is to determine how the β-glucan receptor EphA2 interacts with other
host signaling molecules to induce an inflammatory response in both the oral mucosa and leukocytes, and induce
oral epithelial cell invasion during OPC. Aim 1 will evaluate the role of EphA2 activation and downstream
signaling in oral epithelial cells during oral C. albicans infection in vitro and in vivo. Aim 2 will characterize the
mechanisms by which EphA2 activation triggers neutrophil fungicidal activity. The long-term goal of this
research is to determine how host receptors recognize invading fungi and maintain mucosal immunity so that
new drugs and strategies to treat and prevent fungal diseases can be developed.
The candidate, Dr. Swidergall, has a longstanding interest in mycology research. After completing the
mentored phase of this K99, his goal is to become an assistant professor at a leading academic research
institute, where he plans to continue his research on the role of critical host cell receptors in the pathogenesis
of OPC. He also plans to teach students and train future scientists. This K99/R00 proposal is designed to
complement Dr. Swidergall's prior research training and provide him with the necessary technical and
intellectual expertise to become an independent investigator. The training he will receive in the K99 phase will
substantially enhance his career prospects, and make him highly competitive for faculty positions in top
research institutes. Dr. Swidergall's primary mentor, Dr. Scott G. Filler, and co-mentor, Dr. Michail S. Lionakis,
were carefully selected for their relevant, diverse, and complementary expertise to cover all elements of his
proposal. In addition, Dr. Swidergall has assembled an advisory committee of a diverse group of scientists to
oversee his scientific progression and career development during his transition to an independent investigator.
All members of this committee are senior scientists with extensive experience in mentoring postdocs.
抽象/总结
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mucosal IgA Prevents Commensal Candida albicans Dysbiosis in the Oral Cavity.
- DOI:10.3389/fimmu.2020.555363
- 发表时间:2020
- 期刊:
- 影响因子:7.3
- 作者:Millet N;Solis NV;Swidergall M
- 通讯作者:Swidergall M
Immunosurveillance of Candida albicans commensalism by the adaptive immune system.
- DOI:10.1038/s41385-022-00536-5
- 发表时间:2022-05
- 期刊:
- 影响因子:8
- 作者:Swidergall, Marc;LeibundGut-Landmann, Salome
- 通讯作者:LeibundGut-Landmann, Salome
Rapid proliferation due to better metabolic adaptation results in full virulence of a filament-deficient Candida albicans strain.
- DOI:10.1038/s41467-021-24095-8
- 发表时间:2021-06-23
- 期刊:
- 影响因子:16.6
- 作者:Dunker C;Polke M;Schulze-Richter B;Schubert K;Rudolphi S;Gressler AE;Pawlik T;Prada Salcedo JP;Niemiec MJ;Slesiona-Künzel S;Swidergall M;Martin R;Dandekar T;Jacobsen ID
- 通讯作者:Jacobsen ID
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marc Swidergall其他文献
Marc Swidergall的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marc Swidergall', 18)}}的其他基金
Novel Candida albicans host receptors during infection and immune response
感染和免疫反应期间新型白色念珠菌宿主受体
- 批准号:
9916953 - 财政年份:2019
- 资助金额:
$ 23.67万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 23.67万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 23.67万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 23.67万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 23.67万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 23.67万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 23.67万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 23.67万 - 项目类别: